OBJECTIVES To evaluate neuromuscular signs and symptoms in patients with newly diagnosed hypothyroidism and hyperthyroidism. METHODS A prospective cohort study was performed in adult patients with ...

Institute of Neuroscience, Department of Neurology, University of Helsinki, Finland Dr Laura Hokkanen, Institute of Neuroscience, Department of Neurology, University of Helsinki, Finland. OBJECTIVE ...

As a chronic progressive disease, Parkinson's disease (PD) has a presymptomatic interval; that is, a period during which the pathological process has begun, but motor signs required for the clinical ...

Correspondence to Dr Mahima Kapoor, UCL Queen Square Institute of Neurology, London WC1N 3BG, UK; mahima.kapoor{at}monash.edu Background Arterial and venous thromboembolic events (TEEs) have been ...

Faculty of Medicine MS/MRI Research Group, University of British Columbia, Vancouver, Canada Helen Tremlett, PhD, Department of Medicine (Neurology), rm S178, 2211 Wesbrook Mall, University of British ...

Correspondence to Dr Tao Xie, Department of Neurology, University of Chicago Medicine, Chicago, IL 60637, USA; txie{at}bsd.uchicago.edu Objective To evaluate the long-term effect of 60 Hz stimulation ...

Background and objective: Cryoglobulinaemic neuropathy (CN) is probably common, as it is usually related to HCV infection. The aim of this study was to delineate the clinical spectrum of CN in a large ...

1 Department of Neurology, Royal Victoria Infirmary, Newcastle upon Tyne, UK 2 Department of Neurophysiology, Royal Victoria Infirmary, Newcastle upon Tyne, UK 3 Department of Rheumatology, Royal ...

Correspondence to Professor Yoon-Ho Hong, Neurology, Neuroscience Research Institute, Medical Research Council, Seoul National University College of Medicine, Seoul Metropolitan Government Boramae ...

Background Sleep difficulties are common in people with multiple sclerosis (MS), but whether associations between poor sleep quality and quality of life are independent of MS symptoms, obesity and ...

Background We evaluated safety and efficacy of intravenous recombinant tissue Plasminogen Activator plus endovascular (bridging) therapy compared with direct endovascular therapy in patients with ...